MedTrace Logo

Hemodynamic Characteristics of Patients With SARS-CoV-2

NCT04337983 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-09-14

No results posted yet for this study

Summary

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been declared a public health emergency of international concern. Hospitalized COVID-19-positive patients requiring ICU care is increasing along with the course of epidemic. A large number of these patients developed acute respiratory distress syndrome (ARDS) according to current data. However, the related hemodynamic characteristic has so far been rarely described.

Conditions

  • Coronavirus
  • SARS-CoV-2
  • COVID-19
  • Acute Respiratory Distress Syndrome
  • Shock
  • Acute Circulatory Failure
  • Left Ventricular Dysfunction
  • Fluid Overload

Interventions

DEVICE

Transpulmonary thermodilution

Obtained by averaging the results of three thermodilution measurements. Each thermodilution is performed by injecting a bolus (15 mL) of cold saline (less than 10°C)

DEVICE

Echocardiography

Daily echocardiography evaluation

Sponsors & Collaborators

  • Bicetre Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-13
Primary Completion
2020-10-30
Completion
2020-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04337983 on ClinicalTrials.gov